Newstrail.com

Search

CMF Devices Market: $2.9B by 2031, Fueled by Sports Sector Demand

CMF Devices Market $2.9B by 2031, Fueled by Sports Sector Demand

According to a report by Altus Market Research titled, “Global Craniomaxillofacial (CMF) Devices and Equipment Market Analysis 2022-2031 by Product(Cranial Flap Fixation; CMF Distraction; Thoracic Fixation); Material(Metals and Alloys; Polymers); By End-User(Hospital; Surgical Center), Application”, the global craniomaxillofacial (CMF) devices and equipment market reached a value of nearly $1,513.2 million in 2021, having grown at a compound annual growth rate (CAGR) of 4.0% since 2016. The market is expected to grow from $1,513.2 million in 2021 to $2,173.9 million in 2026 at a rate of 7.5%. The market is then expected to grow at a CAGR of 6.0% from 2026 and reach $2,908.3 million in 2031.

Growth in the historic period resulted from rapid growth in elderly population, increased number of accidents, increased healthcare expenditure, growth in the number of healthcare facilities, and economic growth in emerging markets. The market was restrained by coronavirus (COVID-19) outbreak, lack of surgical resources and side effects and complications of craniofacial surgery. Going forward, rising incidents of road accidents, a rise in sports-related injuries, increasing incidences of occupational accidents and improving healthcare facilities. Factors that could hinder the growth of the craniomaxillofacial (CMF) devices and equipment market in the future include challenges due to regulatory changes, high costs of craniomaxillofacial surgeries and lack of skilled labor.

The craniomaxillofacial (CMF) devices and equipment market is segmented by product into cranial flap fixation, CMF distraction, temporomandibular joint replacement, thoracic fixation, MF plate and screw fixation, and other products. The MF plate and screw fixation market was the largest segment of the craniomaxillofacial (CMF) devices and equipment market segmented by product, accounting for 55.1% of the total in 2021. Going forward, the temporomandibular joint replacement segment is expected to be the fastest growing segment in the craniomaxillofacial (CMF) devices and equipment market segmented by product, at a CAGR of 8.4% during 2021-2026.

Request Research Sample with Latest Industry Insights (270+ Pages Report): https://altusmarketresearch.com/reports/sample/43270

The craniomaxillofacial (CMF) devices and equipment market is also segmented by material into metals and alloys, polymers, bioabsorbable materials, and other materials. The metals and alloys market was the largest segment of the craniomaxillofacial (CMF) devices and equipment market segmented by material, accounting for 59.5% of the total in 2021. Going forward, the bioabsorbable materials segment is expected to be the fastest growing segment in the craniomaxillofacial (CMF) devices and equipment market segmented by material, at a CAGR of 8.7% during 2021-2026.

The craniomaxillofacial (CMF) devices and equipment market is also segmented by end-user into hospital, ambulatory surgical center and other end-users. The hospital market was the largest segment of the craniomaxillofacial (CMF) devices and equipment market segmented by end-user, accounting for 67.2% of the total in 2021. Going forward, the ambulatory surgical center segment is expected to be the fastest growing segment in the craniomaxillofacial (CMF) devices and equipment market segmented by end-user, at a CAGR of 8.5% during 2021-2026.

The craniomaxillofacial (CMF) devices and equipment market is also segmented by application into neurosurgery and ENT, orthognathic and dental surgery, plastic surgery, and other applications. The orthognathic and dental surgery market was the largest segment of the craniomaxillofacial (CMF) devices and equipment market segmented by application, accounting for 52.1% of the total in 2021. Going forward, the neurosurgery and ENT segment is expected to be the fastest growing segment in the craniomaxillofacial (CMF) devices and equipment market segmented by application, at a CAGR of 8.4% during 2021-2026.

North America was the largest region in the craniomaxillofacial (CMF) devices and equipment market, accounting for 30.4% of the total in 2021. It was followed by Asia Pacific, and then the other regions. Going forward, the fastest-growing regions in the craniomaxillofacial (CMF) devices and equipment market will be Asia Pacific, and, North America where growth will be at CAGRs of 8.1% and 7.8% respectively. These will be followed by Western Europe, and, South America where the markets are expected to grow at CAGRs of 7.6% and 7.1% respectively.

The global craniomaxillofacial (CMF) devices and equipment market is highly consolidated with small number of large players dominating the market. The top ten competitors in the market made up to 82.13% of the total market in 2021. Johnson & Johnson (DePuy Synthes) was the largest competitor with 26.96% share of the market, followed by Stryker Corporation with 19.29%, Medtronic Plc with 13.79%, Zimmer-Biomet with 9.13%, Integra Lifesciences Corporation with 6.78%, KLS Martin L. P with 2.56%, B. Braun with 1.46%, Medartis AG with 1.10%, Matrix Surgical USA with 0.60%, and Acumed with 0.46%.

The top opportunities in the craniomaxillofacial (CMF) devices and equipment market segmented by product will arise in the MF plate and screw fixation market segment, which will gain $345.8 million of global annual sales by 2026. The top opportunities in the craniomaxillofacial (CMF) devices and equipment market segmented by material will arise in the metals and alloys market segment, which will gain $373.7 million of global annual sales by 2026. The top opportunities in the craniomaxillofacial (CMF) devices and equipment market segmented by end-user will arise in the hospitals market segment, which will gain $418.6 of global annual sales by 2026. The top opportunities in the craniomaxillofacial (CMF) devices and equipment market segmented by application will arise in the orthognathic and dental surgery market segment, which will gain $323.5 of global annual sales by 2026. The craniomaxillofacial (CMF) devices and equipment market size will gain the most in USA at $213.7 million.

Market-trend based strategies for the craniomaxillofacial (CMF) devices and equipment market include focus on artificial intelligence (AI), focus on 3D printing technology, focus on patient specific implants and focus on use integrated robotics and digital health technologies.

Player-adopted strategies in the craniomaxillofacial (CMF) devices and equipment market include focus on strengthening market position through acquisition of similar business companies, focus on strategic partnerships and focuses on expanding product portfolio through new product launches.

To take advantage of the opportunities, Altus Market Research recommends the craniomaxillofacial (CMF) devices and equipment companies to use artificial intelligence (AI), increase use of 3D printing technology, offer patient specific implants, expand in emerging markets, provide competitively priced offerings, continue to use B2B promotions, continue to target maxillofacial surgeons and increase focus on fast-growing end-users.

Competitive Landscape – Details on the competitive landscape of the market, estimated market shares and company profiles of the leading players.

KLS Martin L.P, B. Braun, Medartis AG, Matrix Surgical USA, Acumed, Roche India Pvt Ltd, Abbott India Limited, bioMerieux India, Becton Dickinson Private Limited, Danaher Corporation, Simens Healthcare, Beckman Coulter Inc India, Ortho Clinical Diagnostics, Bio-Rad Laboratories Inc, Sysmex Corporation, Thermo Fisher Scientific Inc, Asymchem, Sino Biological, ACROBiosystems, QPS, Wuxi Biologics, Qiagen Pvt Ltd, INVACARE POIRIER Fondettes, ESSILOR INTERNATIONAL Charenton-le-Pont, TERUMO FRANCE SAS Guyancourt, CAREFUSION FRANCE 309 SAS Le Pont-de-Claix, TOURLAVILLE DISTRIBUTION Cherbourg-Octeville, HARMONIE MEDICAL SERVICE Saint-Benoit, Balton, HTL-Strefa, TZMO, Consultronix, Kelyniam Global Inc, AbbVie Corporation, ABK Biomedical, Acart Equipment Ltd, A.R. Medicom Inc, Delphos Implants, Osteomed, Anatomics Pty Ltd, Bioplate Inc., Calavera Surgical Design, Innovasis

Facebook
Twitter
LinkedIn
Pinterest